HR 4110 United States House · 117th Congress

Reducing Hereditary Cancer Act of 2021

Summary

Reducing Hereditary Cancer Act of 2021 This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Jun 2021

Committee Review

Floor Vote

President

Introduced Jun 23, 2021 Last action Jun 24, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jun 24, 2021

Committee

Referred to the Subcommittee on Health.

lower

Jun 23, 2021

Committee

Referred to the Subcommittee on Health.

lower

Jun 23, 2021

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Jun 23, 2021

Introduced

Introduced in House

lower

1 primary · 56 co-sponsors